Crystal-induced inflammation of the kidneys: Results from human studies, animal models, and tissue-culture studies

Clinical and Experimental Nephrology

Volumn 8, Issue 2, 2004, Pages 75-88

  Khan, Saeed R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

End stage renal disease; Fibrosis; Inflammation; Oxalate; Venin angiotensin

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; CALCIUM PYROPHOSPHATE; HEPARAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; URATE; URIC ACID; WHEWELLITE;

ANIMAL CELL; ANIMAL MODEL; CHRONIC KIDNEY FAILURE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; KIDNEY FIBROSIS; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE DISORDER; MALE; MITOGENESIS; MONOCYTE; NEPHRITIS; NEUTROPHIL; NONHUMAN; PROSTAGLANDIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TISSUE CULTURE;

EID: 3142659602     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0292-0     Document Type: Review

References (150)

1. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN. Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-α-induced oxidant stress. Am J Physiol 1999;276: L979-88.
2. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN. Antioxidant treatment attenuates cytokine and chemokine levels in murine macrophages following silica exposure. Toxicol Appl Pharmacol 1999;158:211-20.
3. Tanaka S, Choe N, lwagaki A, Hemenway DR, Kagan E. Asbestos exposure induces MCP-1 secretion by pleural mesothelial cells. Exp Cell Res 2000;26:241-55.
4. Nasreen N, Hartman DL, Mohammed KA, Anatony VB. Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells. Am J Respir Crit Care Med 1998;158:971-8.
5. Matsukawa A, Miyazaki S, Maeda T, Tanase S, Feng L, Ohkawara S, et al. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide or monosodium urate crystal-induced arthritis in rabbits: role of tumor necrosis factor alpha, interleukin-1, and interleukin-8. Lab Invest 1998;78: 973-85.
6. Schumacher HR Jr. Synovial inflammation, crystals, and osteoarthritis. J Rheumatol 1995;43:S101-3.
7. Anderson L, McDonald JR. The origin, frequency, and significance of microscopic calculi in the kidney. Surg Gynecol Obstet 1946;82:275-82.
8. Khan SR. Renal papillary changes in a patient with calcium oxalate lithiasis. Urology 1984;23:194-9.
9. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003;111:607-16.
10. Randall A. Papillary pathology as precursor of primary renal calculus. J Urol 1940;44:580-9.
11. Lemley KV, Kriz W. Anatomy of the renal interstitium. Kidney Int 1991;39:370-81.
12. Nath K. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
13. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002;283:F861-75.
14. Agarwal R. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am J Physiol Renal Physiol 2003;284:F863-9.
15. Lieske JC, Spargo BH, Toback FG. Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 1992;148:1517-19.
16. Mandell I, Krauss E, Millan JC. Oxalate-induced acute renal failure in Crohn's disease. Am J Med 1980;69:628-32.
17. Gelbert DR, Brewer LL, Fajardo LF, Weinstein AB. Oxalosis and chronic renal failure after intestinal bypass. Arch Int Med 1977;137:239-43.
18. Wharton R, D'Agati V, Magun AM, Whitlock R, Kunis CL, Appel GB. Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 1990;34:116-21.
19. Baggio B, Gambaro G, Ossi E, Favaro S, Borsatti A. Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 1983;129:1161-4.
20. Huang H-S, Ma M-C, Chen C-F, Chen J. Lipid peroxidafion and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 2003;62:1123-8.
21. Khan SR, Finlayson B, Hackett RL. Experimental calcium oxalate nephrolithiasis in the rat, role of renal papilla. Am J Pathol 1982;107:59-69.
22. Khan SR, Finlayson B, Hackett R. Histologic study of the early events in oxalate-induced intranephronic calculosis. Invest Urol 1979;17:199-203.
23. Khan SR. Animal models of kidney stone formation: an analysis. World J Urol 1997;15:236-43.
24. De Bruijn WC, Boeve ER, van Run PR, van Miert PP, de Water R, Romjin JC, et al. Etiology of CaOx nephrolithiasis in rats. I. Can this be a model for human stone formation? Scanning Microsc 1995;9:103-14.
25. Khan SR. Experimental CaOx nephrolithiasis and the for-mation of human urinary stones. Scanning Microsc 1995;9:89-100.
26. Khan SR, Shevock PN, Hackett R. Urinary enzymes and CaOx urolithiasis. J Urol 1989;142:846-9.
27. Khan SR, Finlayson B, Hackett RL. Relationship between experimentally induced crystalluria and relative supersaturation of various stone salts in rats. Urol Res 1984;12:271-3.
28. Khan SR, Shevock PN, Hackett RL. Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 1992;147:226-30.
29. Thamilselvan S, Hackett RL, Khan SR. Lipid peroxidation in ethylene glycol-induced hyperoxaluria and CaOx nephrolithiasis. J Urol 1997;157:1059-63.
30. Khan SR, Johnson JM, Peck AB, Cornelius JM, Glenton PA. Expression of osteopontin in rat kidneys: induction during ethylene glycol-induced calcium oxalate nephrolithiasis. J Urol 2002;168:1173-81.
31. Moriyama MT, Glenton PA, Khan SR. Expression of inter-α-inhibitor- related proteins in kidneys and urine of hyperoxaluric rats. J Urol 2001;165:1687-92.
32. Iida S, Peck AB, Johnson-Tardieu J, Moriyama M, Glenton PA, Byer KJ, et al. Temporal changes in mRNA expression for bikunin in the kidneys of rats during CaOx nephrolithiasis. J Am Soc Nephrol 1999;16:986-96.
33. Khan SR, Thamilselvan S. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 2000;4:305-12.
34. Khan SR. CaOx crystal interaction with renal epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 1995;23:71-9.
35. Sarica K, Yagci F, Bakir K, Erbagci A, Erturhan S, Ucak R. Renal tubular injury induced by hyperoxaluria: evaluation of apoptotic changes. Urol Res 2001;29:34-7.
36. DeWater R, Noordermeer C, van der Kwast TH, Nizze H, Boeve ER, Kok DJ, Schroeder FH. CaOx nephrolithiasis in rats: the effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 1999;33:761-71.
37. Toblli JE, Ferder L, Stelia I, Angerosa M, Inserra F. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 2001;166:275-80.
38. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 2002;168:1550-5.
39. Muller GA, Rodemann HP. Characterization of human renal fibroblasts in health and disease: immunophenotyping of cultural epithelial cells and fibroblasts derived from kidney with histologically proven interstitial fibrosis. Am J Kidney Dis 1991;17:680-3.
40. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-26.
41. Gokhale JA, Glenton PA, Khan SR. Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model. J Urol 2001;166: 1492-7.
42. Gokhale JA, Glenton PA, Khan SR. Immunocytochemical localization of Tamm-Horsfall protein and osteopontin in a rat nephrolithiasis model. Nephron 1996;73:456-61.
43. Suzuki K, Tanaka T, Miyazawa K, Nakajima C, Moriyama M, Suga K, et al. Gene expression of prothrombin in human and rat kidneys, basic and clinical approach. J Am Soc Nephrol 1999;10: S408-11.
44. Iida S, Inoue M, Yoshi S, Yanagaki T, Chikama S, Shimada S, et al. Molecular detection of heparan sulfate proteoglycan mRNA in rat kidneys during CaOx nephrolithiasis. J Am Soc Nephrol 1999;10:S412-16.
45. Marengo SR, Chen DHC, Kaung HLC, Resnick MI, Yang L. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 2002;167:2192-7.
46. Katsuma S, Shiojima S, Hirasawa A, Takagaki K, Kaminishi Y, Koba M, et al. Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 2002;296:544-52.
47. Umekawa T, Hatanaka Y, Kurita T, Khan SR. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in the rat kidney. J Am Soc Nephrol 2004;15:635-44.
48. Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1995;48:439-48.
49. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, et al. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 1999; 56:571-80.
50. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 2003;14:139-47.
51. Lieska JC, Toback FG. Renal cell-urinary crystal interactions. Curr Opin Nephrol Hypertens 2000;9:349-55.
52. Fries E, Blom AM. Bikunin: not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 2000;32:125-37.
53. Balduyck M, Albani D, Jourdain M, Mizon C, Tournoys A, Drobecq H, et al. Inflammation-induced systemic proteolysis of inter-alpha-inhibitor in plasma from patients with sepsis. J Lab Clin Med 2000;135:188-98.
54. Hackett RL, Shevock PN, Khan SR. Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol Res 1994;22:197-204.
55. Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA, et al. Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 1999;10:S457-63.
56. Miller C, Kennington L, Cooney R, Kohjimoto Y, Cao LC, Honeyman T, et al. Oxalate toxicity in renal epithelial cells: characteristics of apoptosis and necrosis. Toxicol Pharmacol 2000;162: 132-41.
57. Koul H, Kenington L, Nair G, Honeyman T, Menon M, Scheid CR. Ox-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Comm 1994;205:1632-37.
58. Scheid CR, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T, et al. Ox toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 1996;49:413-19.
59. Koul H, Kenington L, Honeyman T, Jonassen J, Menon M, Scheid CR. Activation of the c-myc gene mediates the mitogenic effects of Ox in LLC-PK1 cells, a line of renal epithelial cells. Kidney Int 1996;50:1525-30.
60. Riese RJ, Mandel NS, Wiessner JH, Mandel GS, Becker CJ, Kleinman JC. Cell polarity and CaOx crystal adherence to cultured collecting duct cells. Am J Physiol 1992;262:F177-84.
61. Verkoelen CF, van der Broom BG, Houtsmuller AB, Schroeder FH, Romijn JC. Increased CaOx monohydrate crystal binding to injured renal epithelial cells in culture. Am J Physiol 1998;274: F958-65.
62. Bigelow MW, Wienner JH, Kleinman JC, Mandel NS. Surface exposure of PS increases CaOx crystal attachment to IMCD cells. Am J Physiol 1999;272:F55-62.
63. Wiessner JH, Hasegawa AT, Hung LY, Mandel NS. Oxalate-induced exposure of PS on surface of renal epithelial cells in culture. J Am Soc Nephrol 1999;10:S441-5.
64. Mandel NS. Crystal-membrane interaction in kidney stone disease. J Am Soc Nephrol 1994;5:S37-42.
65. Lieske JC, Swift H, Martin T, Patterson B, Toback FG. Renal epithelial cells rapidly bind and internalize CaOx monohydrate crystals. Proc Natl Acad Sci USA 1994;91:6987-91.
66. Lieske JC, Leonard R, Swift H, Toback FG. Adhesion of CaOx monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 1996;270:F192-9.
67. Verkoelen CF, van der Broom BG, Kok DJ, Schroeder FH, Romijn JC. Attachment sites for particles in the urinary tract. J Am Soc Nephrol 1999;10:S430-5.
68. Verkoelen CF, van der Broom BG, Kok DJ, Houtsmuller AB, Schroeder FH, Romijn JC. Cell type-specific acquired protection from crystal adherence by renal tubule cells in culture. Kidney Int 1999;55:1426-33.
69. Ebisuno S, Nishihata M, Inagaki T, Umehara M, Kohjimoto Y. Bikunin prevents adhesion of CaOx crystal to renal tubular cells in human urine. J Am Soc Nephrol 1999;10:S436-40.
70. Jonassen JA, Cooney R, Kennington L, Gravel K, Honeyman T, Scheid CR. Ox-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol 1999;10:S446-51.
71. Thamilselvan S, Khan SR, Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 2003;31:3-9.
72. Hammes MS, Lieska JC, Pawar S, Spargo BH, Toback FG. Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 1995;48:501-9.
73. Lieske JC, Hammes MS, Hoyer JR, Toback FG. Renal cell osteopontin production is stimulated by CaOx monohydrate crystals. Kidney Int 1997;51:679-86.
74. Iida S, Peck AB, Byer KJ, Khan SR. Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 1999;162:1480-6.
75. Umekawa T, Chegini N, Khan SR. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 2002;61:105-12.
76. Umekawa T, Chegini N, Khan SR. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 2003;18:664-9.
77. Rovin BH, Phan LT. Chemotactic factors and renal inflammation. Am J Kidney Dis 1998;31:1065-84.
78. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal diseases: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000;11:152-76.
79. Kaneto H, Fukuzaki A, Ishidoya S, Takeda A, Ogata Y, Sasaki T, et al. mRNA expression of chemokines in rat kidneys with ureteral obstruction. 2000;91:69-74.
80. Prodjosudjadi W, Gerritsma JST, Klar-Mohamed N, Gerritsen AF, Bruijn JA, Daha MR, et al. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995;48:1477-82.
81. Kakizakai Y, Waga S, Sugimoto K, Tanaka H, Nukii K, Takeya M, et al. Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells. Kidney Int 1995;48:1866-74.
82. Rovin BH, Yoshimura T, Tan L. Cytokine-induced production of MCP-1 by cultured human mesangial cells. J Immunol 1992;148: 2148-53.
83. Schmouder RL, Streiter RM, Kunkel SL. Interferon gamma regulation of human renal cortical epithelial cell-derived MCP-1. Kidney Int 1993;44:43-9.
84. Diamond R, Kees-Folts D, Ding G, Frye JE, Retrepo N. Macrophages, monocyte chemoattracant peptide-1, and THF-B1 in experimental hydronephrosis. Am J Physiol 1994;266:F926-33.
85. Wung BS, Cheng JJ, Chao YJ, Lin J, Shyy YJ, Wang DL. Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells. Am J Physiol 1996;270:H1462-8.
86. Satriano JA, Shuldner M, Hora K, Xing Y, Shan Z, Schlondorff D. Oxygen radicals as second messengers for expression of MCP, JE/MCP-1, and the monocyte colony stimulating factor CSF-1 in response to tumor necrosis factor-α and immunoglobulin G. J Clin Invest 1993;92:1564-71.
87. Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular diseases. Am J Kidney Dis 1996;27:640-6.
88. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Stallone G, Schena FP. Monocyte chemotactic peptide-1 expression in acute renal transplant rejection. Transplantation 1997;63:414-20.
89. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti G, Remuzzi G, et al. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 1995;73:804-9.
90. Jonassen JA, Cao LC, Honeyman T, Scheid CR. Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 2003;13:55-72.
91. Khand FD, Gordge MP, Robertson WG, Noronha-Dutra AA, Hothersall JS. Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 2002;32:1339-50.
92. Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP. Production of superoxide through NADH oxidase in thick ascending limb of the loop in rat kidney. Am J Physiol 2002;282:F1111-19.
93. Chaturvedi LS, Koul S, Sekhon A, Bhandari A, Menon M, Koul HK. Oxalate selectively activates the p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathway in renal epithelial cells. J Biol Chem 2002;277:13321-30.
94. Koul HK, Menon M, Chaturvedi LS, Koul S, Sekhon A, Bhandari A, et al. COM crystals activate the p38 mitogen-activated protein kinase (MAPK) signal transduction pathway in renal epithelial cells. J Biol Chem 2002;277:36845-52.
95. Wang SS, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakkar RV, et al. Mice lacking renal chloride channel, CLC5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Human Mol Genet 2000;9: 2937-45.
96. Saarela T, Lanning P, Koivisto M, Paavilainen T. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow-up. Eur J Pediatr 1999;158:668-72.
97. Kim Y-G, Kim B, Kim M-K, Chung S-J, Han H-J, Ryu J-A, et al. Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant 2001;16:2303-9.
98. Laberke HG. Pathological anatomy, etiology and pathogenesis of nephrocalcinosis. In: Bichler KH, Strohmaier WL, editors. Nephrocalcinosis, calcium antagonists and kidney. New York: Springer. 1988;67-104.
99. Lau K. Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis. Kidney Int 1989;36:918-37.
100. De Water R, Boeve ER, Miert PP, Deng G, Cao LC, Stijnen T, et al. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc 1996;10:591-603.
101. Strohmaier WL, Seeger RD, Osswald H, Bichler KH. Reduction of vitamin D-induced stone formation by calcium antagonist. Urol Res 1994;22:301-3.
102. Caulfield JB, Schrag PE. Electron microscopic study of renal calcification. Am J Pathol 1964;44:365-81.
103. Nelde H-J, Bichler KH, Strohmaier WL, Kriz W. Nephrocalcinosis in the kidney of the rat on atherogenic diet and the effect of calcium antagonists (Nifedipine). In: Bichler KH, Strohmaier WL, editors. Nephrocalcinosis, calcium antagonists and kidney. New York: Springer 1988;113-25.
104. Strohmaier WL, Bichler KH (1988) Influence of calcium antagonists (Nifedipine) on the excretion of calcium and other substances relevant for stone formation in rats with nephrocalcinosis (induced by atherogenic diet). In: Bichler KH, Strohmaier WL, editors. Nephrocalcinosis, calcium antagonists and kidney. New York: Springer 1988;126-33.
105. Burgess NA, Reynolds TM, Williams N, Pathy A, Smith S. Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids. Urol Res 1995;23:239-42.
106. Cockell KA, L'Abbe MR, Belonje B. The concentration and ratio of dietary calcium and phosphorus influence development of nephrocalcinosis in female rats. J Nutr 2002;132:252-6.
107. Giminez L, Walker WG, Tew WP, Hermann. Prevention of phosphate-induced progression of uremia in rats with 3-phosphocitric acid. Kidney Int 1982;22:36-41.
108. Cozzolino M, Dusso AS, Kiapis H, Finch J, Lu Y, Burke SK, et al. The effects of Sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol 2002;13:2299-308.
109. Cahu H, El-Maadawy S, McKee MD, Tenenhouse HS. Renal calcification in mice homozygous for disrupted type IIa Na/Pi cotransporter gene NPt2. J Bone Miner Res 2003;18:644-57.
110. Cao G, Yang G, Timme TL, Saika T, Truong LD, Satoh T, et al. Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol 2003;162:1241-8.
111. Luyckx VA, Leclercq B, Dowland LK, Yu AS. Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel. Proc Natl Acad Sci 1999;96:12174-9.
112. Piwon N, Gunther W, Schwake M, Bosal MR, Jentsch TJ. C1C5 C1 channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 2000;408:369-73.
113. Aihara K, Byer KJ, Khan SR. Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 2003;64:1283-91.
114. Cheung HS, McCarty DJ. Mechanisms of connective tissue damage by crystals. Rheum Dis Clin North Am 1988;14:365-76.
115. Cheung HS. The role of crystals in articular tissue degeneration. Curr Rheumatol Res 1999;1:128-31.
116. Cheung HS, Story MT, McCarty DJ. Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthritis Rheum 1984;27:668-74.
117. Mitchell PG, Pledger WJ, Cheung HS. Molecular mechanism of basic calcium phosphate crystal-induced mitogenesis. J Biol Chem 1989;264:14071-7.
118. Cheung HS, Mitchell PG, Pledger WJ. Induction of c-fos and c-myc protooncogenes by basic calcium phosphate crystals: effect of beta-interferon. Cancer Res 1989;49:134-8.
119. Nair D, Misra RP, Sallis JD, Cheung HS. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway. J Biol Chem 1997;272:18920-5.
120. Brogley MA, Cruz M, Cheung HS. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/p44 mitogen-activated protein-kinase signal transduction pathway. J Cell Physiol 1997;180:215-24.
121. Reuben PM, Brogley MA, Sun Y, Cheung HS. Molecular mechanisms of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. J Biol Chem 2002;277:15190-8.
122. Bai G, Howell DS, Howard GA, Roos BA, Cheung HS. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts. Osteoarthritis Cartilage 2001;9:416-22.
123. Cotran RS, Kumar V, Robbins SL. Robbins pathologic basic of disease. The musculoskeletal system. New York: WB Saunders 1989;1355-63.
124. Moran ME. Uric acid stone disease. Front Biosci 2003;8:1339-55.
125. Waisman J, Mwasi LM, Bluestone R, Klinenberg JR. Acute hyperuricemic nephropathy in rats, an electron microscopic study. Am J Pathol 1975;81:367-78.
126. Toblli JE, DeRosa G, Lago N, Angerosa M, Nyberg C, Pagano P. Potassium citrate administration ameliorates tubulointerstitial lesions in rats with uric acid nephropathy. Clin Nephrol 2001;55: 59-68.
127. Mazzali M, Hughes J, Kim Y-G, Jefferson JA, Kang D-H, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001;38:1101-6.
128. Mazzali M, Kanellis J, Han L, Feng L, Xia Y-Y, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991-7.
129. Johnson RJ, Kang DH, Feig D, Kivlighn S, Watanabe S, Tuttle KR, et al. Is there a pathologic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1-8.
130. Wu X, Wakamiya M, Vaishnav S, Geske R, Montgomery C Jr, Jones P, et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci 1994;91:742-6.
131. Emmerson BT, Cross M, Osborne JM, Axelsen RA. Reaction of MDCK cells to crystals of monosodium urate monohydrate crystals and uric acid. Kidney Int 1990;37:36-43.
132. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein-kinase and cyclooxygenase. Hypertension 2003;41:1287-93.
133. McMillan RM, Hasselbacher P, Hahn JL, Harris ED Jr. Interaction of murine macrophages with monosodium urate crystals: stimulation of lysosomal enzyme release and prostaglandin synthesis. J Rheumatol 1981;8:555-62.
134. Alwan WH, Dieppe PA, Elson CJ, Bradfield JW. Hydroxyapatite and urate crystal-induced cytokine release by macrophages. Ann Rheum Dis 1989;48:476-82.
135. Netea MG, Kullberg BJ, Blok WL, Netea RT, Van der Meer JWM. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 1997;89:577-82.
136. Ginsberg MH, Kozin F, Chow D, May J, Skosey JL. Adsorption of polymorphonuclear leukocyte enzymes to monosodium urate crystals. Arthritis Rheum 1977;20:1538-42.
137. Abramson S, Hoffstein ST, Weissmann G. Superoxide anion generation by human neutrophils exposed to monosodium urate. Arthritis Rheum 1982;25:174-80.
138. Abuja PM. Ascorbate prevents prooxidant effects of urate in oxidation of human low-density lipoprotein. FEBS Lett 1999;446: 305-8.
139. Desaulniers P, Fernandes M, Gilbert C, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals. J Leukocyte Biology 2001;70:659-68.
140. Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998;91:602-11.
141. DiGiovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor α from human blood monocytes and synovial cells: cytokine mRNA and protein kinetics and cellular distribution. J Clin Invest 1991;87:1375-81.
142. DiGiovine FS, Malawista SE, Nuki G, Duff GW. Interleukin-1 as a mediator of crystal arthritis: stimulation of T cell and synovial fibroblast mitogenesis by urate crystal induced IL-1. J Immunol 1987;138:3213-18.
143. Guerne PA, Terkeltaub R, Zuraw B, Lotz M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989;32: 1443-52.
144. Terkeltaub R, Zavhariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991;34:894-903.
145. Liu R, O'Connel M, Johnson K, Pritzker K, Mackman N, Terkeltaub R. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein-1 and nuclear factor kappa B transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells. Arthritis Rheum 2000;43:1145-55.
146. Liu R, Aupperle K, Terkeltaub R. Src family protein tyrosine kinase signaling mediates monosodium urate crystal-induced IL-8 expression by monocytic THP-1 cells. J Leukocyte Biol 2001;70:961-8.
147. Hsieh M-S, Ho H-C, Chou D-T, Pan S, Liang Y-C, Hsieh T-Y, et al. Expression of matrix metalloproteinase-9 (Gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages. J Cell Biochem 2003;89:791-9.
148. Seikaly MG, Aarnt BS Jr, Seney FD Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990;86:1352-7.
149. Antus B, Exton MS, Rosivall L. Angiotensin II: a regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 2001;14:25-30.
150. James EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1998;54:775-84.